Katherine Koontz Sanford (July 19, 1915 – September 12, 2005), also known as Katherine Sanford Mifflin, was an American biologist and cancer researcher who worked at the National Cancer Institute for nearly 50 years, serving as head of Laboratory of Cellular and Molecular Biology. In the 1940s she became the first person to successfully clone a mammalian cell in vitro, which allowed for more efficient means of creating pure strains of cells for study. She also developed the first laboratory test to distinguish people with Alzheimer's disease and people predisposed to cancer.
Early life and education Sanford was born July 19, 1915, in Chicago, Illinois, to parents Alta Rache and William James Koontz. She was educated at North Shore Country Day School, a selective prep school in Winnetka, Illinois. She then attended Wellesley College with her two sisters. She graduated from Wellesley with an undergraduate degree in 1937. After receiving her undergraduate degree, she then attended Brown University, where she pursued a master's and doctorate in biology. She studied under zoologist Arthur M. Banta, and graduated with a Ph.D in 1942. She was one of a small distinguished group of women who attended Brown University's graduate biology program in the 1940s.
Career Katherine Sanford spent her first two postdoctoral years teaching biology. From 1941-1942 she taught biology, comparative anatomy, and immunology at Western College for Women in Oxford, Ohio and then moved to Allegheny College in Meadville, Pennsylvania from 1942-1943. Following her time as an instructor, Sanford joined Johns Hopkins School of Nursing in Baltimore, Maryland as assistant director of its science program. She held this position from 1943 to 1947. After her brief interval in teaching, she joined the National Cancer Institute (NCI) cancer laboratory in 1947, where she spent close to 50 years, and the rest of her career, working as a cancer research scientist. Sanford began her career as a research scientist as part of the tissue culture section of the National Cancer Institute's Laboratory of Biology. It did not take her long to make an impact, as almost immediately after joining she made her largest discovery involving a method of cloning mammalian cancer cells in vitro. She was recognized with this discovery with the Ross Harrison Fellowship Award. In 1974 Sanford was appointed head of the cell physiology and oncogenesis section of the NCI's Laboratory of Biochemistry. Following this in 1977, Sanford was further promoted to the head of the in-vitro carcinogenesis section of the Laboratory of Cellular and Molecular Biology. From this position, which she held the rest of her career, she made two more iconic discoveries. In 1985, she designed a test that could recognize genetic predisposition for cancer. Building on this idea in the 90s, she created a test that could differentiate people with a genetic predisposition for cancer from those with Alzheimer's disease. After a 49-year career with the NCI, Stanford officially retired in December 1995, but stayed one extra year to complete her research. Sanford was involved with various biology societies and associations over her career. She founding member of the American Association for Cancer Research. She served on various AACR committees during her career. Additionally, she was a member of the American Society for Cell Biology, the American Society of Human Genetics, the Tissue Culture Association, and the International Society for Cell Biology. In total, Sanford served as a board director or as a committee member on 23 scientific associations during the course of her career.
… excerpt ends here. Continue reading the full article.

